Ivermectin Protects Against Experimental Autoimmune Encephalomyelitis in Mice by Modulating the Th17/Treg Balance Involved in the IL-2/STAT5 Pathway (2023)

Peer-Reviewed Study · Xie Y, Jin C, Sang H, Liu W, Wang J · May 2023

Xie Y et al., 2023-05: Mouse EAE study from a Chinese group showing ivermectin reduced disease severity by shifting T cells toward Treg and away from Th1/Th17, via IL-2/STAT5 signalling.

ivermectin administration reduced the clinical symptoms of EAE mice by preventing the infiltration of inflammatory cells into the CNS.

Xie Y et al., 2023-05: Mouse EAE study from a Chinese group showing ivermectin reduced disease severity by shifting T cells toward Treg and away from Th1/Th17, via IL-2/STAT5 signalling. C12 – this is the paper whose findings the NaturalNews article reports, though the article attributes them to EMBO Molecular Medicine. Study type: mouse EAE model plus in vitro T-cell work; no human subjects. Country: China (Henan University, Kaifeng; Nankai University). Dose/route/schedule: not stated in the abstract captured. Funder/conflicts: 'The authors declare no competing interests.' Comparator: vehicle-treated EAE mice. Outcome measures: clinical EAE score, CNS inflammatory infiltration, cytokine levels – not MRI, relapse rate or human disability. Also filed as IVE-64 (claims C12, C7). Study type: animal.